Evidence map›Paper›PMID 29396563›Full record

ArticleEuropean journal of human genetics : EJHG2018

The RD-Connect Registry & Biobank Finder: a tool for sharing aggregated data and metadata among rare disease researchers.

Sabina Gainotti, Paola Torreri, Chiuhui Mary Wang, Robert Reihs, Heimo Mueller, Emma Heslop, Marco Roos, Dorota Mazena Badowska, Federico de Paulis, Yllka Kodra and 11 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Resources and tools for rare disease variant interpretation.Frontiers in molecular biosciences · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 6 countries.

Sabina GainottiBioethics Unit, Office of the President, Istituto Superiore di Sanità, Rome, Italy. sabina.gainotti@iss.it.ORCID http://orcid.org/0000-0002-6006-9064
Paola TorreriNational Center for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Chiuhui Mary WangFondazione Telethon, Milan, Italy.ORCID http://orcid.org/0000-0003-1163-0959
Robert ReihsInstitute of Pathology, Medical University of Graz, Graz, Austria.
Heimo MuellerInstitute of Pathology, Medical University of Graz, Graz, Austria.
Emma HeslopJohn Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle, UK.
Marco RoosHuman Genetics Department, Leiden University Medical Center, Leiden, The Netherlands.
Dorota Mazena BadowskaJohn Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle, UK.
Federico de PaulisNational Center for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Yllka KodraNational Center for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Claudio CartaNational Center for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Estrella Lopez MartìnInstitute of Rare Diseases Research (IIER) & Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
Vanessa Rangel MillerAltavoice, San Mateo, CA, USA.
Mirella FilocamoCentro di diagnostica genetica e biochimica delle malattie metaboliche, Istituto Giannina Gaslini, Genoa, Italy.
Marina MoraNeuromuscular Diseases and Neuroimmunology Unit, Fondazione Istituto Neurologico C. Besta, Milan, Italy.
Mark ThompsonHuman Genetics Department, Leiden University Medical Center, Leiden, The Netherlands.
Yaffa RubinsteinOffice of Health Information Programs Development, National Library of Medicine (NLM), National Institutes of Health (NIH), Bethesda, MD, USA.
Manuel Posada de la PazInstitute of Rare Diseases Research (IIER) & Centre for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-8372-4180
Lucia MonacoFondazione Telethon, Milan, Italy.
Hanns LochmüllerJohn Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle, UK.ORCID http://orcid.org/0000-0003-2324-8001
Domenica TaruscioNational Center for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Istituto Superiore di Sanità · ITMuscular Dystrophy UK · GBInstituto de Salud Carlos III · ESLeiden University Medical Center · NLMedical University of Graz · ATTelethon Foundation · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITIstituto Giannina Gaslini · ITNational Institutes of Health · US

Funding

Medical Research Council G1002274Telethon GTB12001
6 · The paper itself

Abstract

In rare disease (RD) research, there is a huge need to systematically collect biomaterials, phenotypic, and genomic data in a standardized way and to make them findable, accessible, interoperable and reusable (FAIR). RD-Connect is a 6 years global infrastructure project initiated in November 2012 that links genomic data with patient registries, biobanks, and clinical bioinformatics tools to create a central research resource for RDs. Here, we present RD-Connect Registry & Biobank Finder, a tool that helps RD researchers to find RD biobanks and registries and provide information on the availability and accessibility of content in each database. The finder concentrates information that is currently sparse on different repositories (inventories, websites, scientific journals, technical reports, etc.), including aggregated data and metadata from participating databases. Aggregated data provided by the finder, if appropriately checked, can be used by researchers who are trying to estimate the prevalence of a RD, to organize a clinical trial on a RD, or to estimate the volume of patients seen by different clinical centers. The finder is also a portal to other RD-Connect tools, providing a link to the RD-Connect Sample Catalogue, a large inventory of RD biological samples available in participating biobanks for RD research. There are several kinds of users and potential uses for the RD-Connect Registry & Biobank Finder, including researchers collaborating with academia and the industry, dealing with the questions of basic, translational, and/or clinical research. As of November 2017, the finder is populated with aggregated data for 222 registries and 21 biobanks.

Indexed as

Computational BiologyGenomicsMetadataBiological Specimen BanksBiomedical ResearchDatabases, FactualHumansInformation DisseminationPatientsRare DiseasesRegistries

Identifiers

PMID29396563
PMCPMC5945774
OpenAlexW2792833459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.